Table 2 Length of hospitalization
Patients characteristics | Length of hospitalization in days (IQR) |
|---|---|
Gender | |
-Male | 6.0 (3.0-13.0) |
-Female | 10.0 (4.0-17.0) |
Age | |
≤ 29 | 9.0 (5.0-47.0) |
30-49 | 9.5 (4.0-16.0) |
50-69 | 7.0 (3.0-15.0) |
≥70 | 9.0 (3.0-13.0) |
MELD score | |
≤ 10 | 8.0 (3.0-21.0) |
11-20 | 4.0 (2.0-10.0) |
21-30 | 10.0 (5.0-16.0) |
31-40 | 11.0 (6.0-27.0) |
> 40 | 10.5 (5.5-24.5) |
Hepatitis B | 7.5 (2.0 – 11.0) |
Hepatitis C | 5.0 (3.0 -10.0) |
Alcohol | 9.0 (4.0 – 17.0) |
Non-alcoholic fatty liver disease | 7.0 (4.0 – 15.0) |
Autoimmune hepatitis | 11.5 (8.0 – 17.0) |
PBC/PSC | 7.5 (2.0 – 20.0) |
Hemochromatosis | 10.5 (10.0 – 11.0) |
Post-liver transplant complication | 12.0 (5.0 – 13.0) |
Cryptogenic/unspecified | 10.0 (5.0 – 24.0) |
Reason of hospitalization | |
-HE | 5.0 (3.0-11.0) |
-Liver-related | 13.0 (7.0-22.8) |
-Non liver-related | 13.0 (7.8-24.0) |
Acute hepatitis | 14.0 (10.3-23.8) |
TIPS | 4.0 (1.0-14.0) |
Prior HE | 5.0 (3.0-12.0) |
Rifaximin | 8.0 (3.0-15.0) |
Use of other antibiotics | 11.0 (5.0-21.0) |